Your Article Summary
(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Adolor Acquires Rights to Clinical-Stage Product Candidate from Eli Lilly and Company
Adolor Corporation, 09/22/09
Adolor Corporation announced that it has acquired from Eli Lilly and Company the exclusive worldwide rights to OpRA III, a clinical–stage product candidate.
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09
FDA Grants Emergency Use Authorization of the Prodesse ProFlu-ST(TM)
Gen-Probe, 10/30/09
Gyrus PlasmaKinetic bipolar coagulation device for liver resection
Australian and New Zealand Journal of Surgery, 11/13/09
Article Search
Sponsor


See Latest Articles


